Hayna Malta-Santos Selected Research

Diffuse Cutaneous Leishmaniasis

1/2020	Differential expression of polyamine biosynthetic pathways in skin lesions and in plasma reveals distinct profiles in diffuse cutaneous leishmaniasis.
10/2017	Resolvin D1 drives establishment of Leishmania amazonensis infection.
2/2015	Arginase I, polyamine, and prostaglandin E2 pathways suppress the inflammatory response and contribute to diffuse cutaneous leishmaniasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hayna Malta-Santos Research Topics

Disease

5	Cutaneous Leishmaniasis 12/2020 - 02/2015
3	Diffuse Cutaneous Leishmaniasis 01/2020 - 02/2015
1	Overweight 06/2020
1	Leishmaniasis 10/2017
1	Infections 10/2017
1	Mucocutaneous Leishmaniasis 04/2016

Drug/Important Bio-Agent (IBA)

2	PolyaminesIBA 01/2020 - 02/2015
2	EicosanoidsIBA 10/2017 - 04/2016
1	CytokinesIBA 12/2020
1	Transforming Growth Factor beta (TGF-beta)IBA 06/2020
1	Amino Acids FDA Link 01/2020
1	Tamoxifen FDA LinkGeneric 01/2018
1	Meglumine AntimoniateIBA 01/2018
1	resolvin D1IBA 10/2017
1	Biomarkers (Surrogate Marker)IBA 10/2017
1	ArginaseIBA 02/2015
1	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2015
1	Dinoprostone (PGE2)FDA Link 02/2015
1	Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA 02/2015

Therapy/Procedure

2	Therapeutics 01/2018 - 10/2017